E Mulate Therapeutics
Biotechnology, 219 Terry Ave N, Seattle, Washington, 98109, United States, 11-50 Employees
Phone Number: 42********
Who is EMULATE THERAPEUTICS
Founded in 2002 and headquartered in Seattle, WA, EMulate Therapeutics is a clinical-stage therapeutic device company. EMulate Therapeutics has invented and patented a groundbreaking tech...
Read More
-
Headquarters: 219 Terry Ave N, Seattle, Washington, 98109, United States
-
Date Founded: 2002
-
Employees: 11-50
-
Revenue: $1 Million to $5 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 3845
|
NAICS Code: 334510 |
Show More
Does something look wrong? Fix it. | View contact records from EMULATE THERAPEUTICS
EMulate Therapeutics Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding EMulate Therapeutics
Answer: EMulate Therapeutics's headquarters are located at 219 Terry Ave N, Seattle, Washington, 98109, United States
Answer: EMulate Therapeutics's phone number is 42********
Answer: EMulate Therapeutics's official website is https://emulatetx.com
Answer: EMulate Therapeutics's revenue is $1 Million to $5 Million
Answer: EMulate Therapeutics's SIC: 3845
Answer: EMulate Therapeutics's NAICS: 334510
Answer: EMulate Therapeutics has 11-50 employees
Answer: EMulate Therapeutics is in Biotechnology
Answer: EMulate Therapeutics contact info: Phone number: 42******** Website: https://emulatetx.com
Answer: Founded in 2002 and headquartered in Seattle, WA, EMulate Therapeutics is a clinical-stage therapeutic device company. EMulate Therapeutics has invented and patented a groundbreaking technology that utilizes precisely targeted, ultra-low radio frequency energy (ulRFE) to specifically regulate signaling and metabolic pathways on the molecular and genetic levels without chemicals, radiation or drugs delivered via a simple-to-use non-invasive device called EMulate Therapeutics Voyager. The companys goal is to transform disease treatment on a global scale with ulRFE. The proprietary technology has the potential to be applied to a wide range of conditions as well as veterinary medicine and non-medical applications. EMulate Therapeutics initial focus is on the treatment of patients with brain cancer who are not well served by conventional standard of care therapies, which often result in poor outcomes and devastating side effects. Additional pre-clinical work is focused on exploring new applications in oncology and pain treatment.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month